There was a progressive increase in the patient-borne cost associated with kidney transplantation, with a reduction in transplant volumes per year. Cost of medications (especially induction regimen) and HLA-tissue typing appear to weigh more on the total cost than other items.
Okwuonu et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: